Topic: artificial intelligence
Two AI firms, Insilico Medicine and A2A Pharmaceuticals, launched a joint company aimed at Duchenne muscular dystrophy and other rare orphan diseases.
IBM and the VA extended their precision oncology partnership in applying Watson technology to the treatment of veterans with late-stage cancer.
Viz.ai, an AI company developing software to detect strokes, has raised $21 million in venture capital to expand its reach to other conditions.
Verge Genomics raised $32 million to bring its AI-generated compounds to the clinic against ALS and Parkinson’s disease in the next three years.
A Google AI accurately predicted patients’ risk of death during hospital stays using raw data from the entirety of their electronic health record.
Juvenescence reeled in $50 million, which will allow it to push forward on its "core projects" and ramp up licensing deals and partnerships.
WuXi AppTec partnered up with Insilico Medicine through a venture capital investment in its AI-driven drug and biomarker discovery platforms.
Zebra Medical Vision unveiled new chest X-ray analysis research, which uses AI to discern 40 clinical findings, alongside a $30 million funding round.
The collaborators will use Mount Sinai’s patient data to train AI to spot when someone is at risk of developing kidney disease.
A new study raises hopes that neural network-powered smartphones can expand access to dermatologist-grade classification of lesions.